Oliver Bathe

Oliver Bathe is associate professor of surgery and oncology at the University of Calgary. He practices as a surgical oncologist with a special interest in hepatobiliary, pancreatic and gastrointestinal tumors. He implemented one of the first trials investigating the role of neoadjuvant chemotherapy in the context of colorectal liver metastases. As a result of his long-standing interest in the multimodality approach to treating colorectal liver metastases, he has served in a leadership role in the NCIC Clinical Trials Group Gastrointestinal Tumor Group, as well as other cooperative clinical trials groups. Bathe also directs a basic and translational research program. Using annotated clinical samples encountered in clinical practice, he and his group have successfully identified biomarkers that refine the diagnosis of gastrointestinal and pancreatic tumors and that facilitate the personalization of clinical management.

1books edited

1chapters authored

Latest work with IntechOpen by Oliver Bathe

The most significant advances in cancer therapy in recent years have involved the development of systemic therapeutics. With improvements in response rates in solid tumors, opportunities have arisen to enhance the effectiveness of surgery. Administration of systemic therapy prior to surgery - neoadjuvant chemotherapy - represents one approach by which clinicians have successfully reduced the extent of surgery and, in some instances, positively impacted on clinical outcomes. This collection of works by expert clinicians from a variety of disciplines represents an exploration of the current knowledge of the role of neoadjuvant chemotherapy in diverse tumor types.

Go to the book